Victory Capital Management
ZYME icon

Victory Capital Management’s Zymeworks ZYME Stock Holding History

Victory Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11M Buy
42,524
+120
+0.3% +$3.05K ﹤0.01% 1860
2026
Q1 		$1.06M Sell
42,404
-501
-1% -$11.9K ﹤0.01% 1817
2025
Q4 		$1.13M Buy
42,905
+8,395
+24% +$183K ﹤0.01% 1774
2025
Q3 		$589K Sell
34,510
-100
-0.3% -$1.43K ﹤0.01% 2007
2025
Q2 		$434K Sell
34,610
-9,660
-22% -$115K ﹤0.01% 2081
2025
Q1 		$527K Sell
44,270
-7,310
-14% -$99.7K ﹤0.01% 2015
2024
Q4 		$755K Sell
51,580
-2,810
-5% -$39.3K ﹤0.01% 1920
2024
Q3 		$683K Sell
54,390
-3,910
-7% -$42.6K ﹤0.01% 1925
2024
Q2 		$496K Buy
58,300
+11,100
+24% +$98.8K ﹤0.01% 1980
2024
Q1 		$497K Buy
+47,200
New +$524K ﹤0.01% 1984
2023
Q3 		– Sell
-123,310
Closed -$1.07M – 2566
2023
Q2 		$1.07M Sell
123,310
-28,640
-19% -$256K ﹤0.01% 1644
2023
Q1 		$1.37M Buy
+151,950
New +$1.33M ﹤0.01% 1532
2021
Q3 		– Sell
-36,810
Closed -$1.28M – 2860
2021
Q2 		$1.28M Sell
36,810
-2,350
-6% -$74.6K ﹤0.01% 1806
2021
Q1 		$1.24M Sell
39,160
-1,740
-4% -$70.7K ﹤0.01% 1818
2020
Q4 		$1.93M Sell
40,900
-6,870
-14% -$319K ﹤0.01% 1526
2020
Q3 		$2.23M Sell
47,770
-23,930
-33% -$822K ﹤0.01% 1411
2020
Q2 		$2.59M Sell
71,700
-178,692
-71% -$6.58M ﹤0.01% 1352
2020
Q1 		$8.88M Sell
250,392
-9,151
-4% -$375K 0.01% 925
2019
Q4 		$11.8M Buy
259,543
+63,553
+32% +$2.31M 0.01% 966
2019
Q3 		$4.86M Buy
+195,990
New +$4.91M 0.01% 1171

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Victory Capital Management's ZYME Position: Q2 2026 in Review

Victory Capital Management increased its Zymeworks (ZYME) stake by 0.28% in Q2 2026, buying an estimated $3.05K and bringing the position to 42,524 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1860.

Victory Capital Management first reported a position in ZYME in Q3 2019 and has held it in 20 quarters since. The position peaked at $11.8M in Q4 2019. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Victory Capital Management held 42,524 shares of Zymeworks worth $1.11M as of Q2 2026.
  • Victory Capital Management bought 120 Zymeworks shares in Q2 2026, an estimated $3.05K.
  • Zymeworks made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1860 holding.
  • Victory Capital Management first reported a position in Zymeworks in Q3 2019 and has held it in 20 quarters since.
  • Victory Capital Management's Zymeworks position peaked at $11.8M in Q4 2019.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.